The Insulin-Like Growth Factors in Adipogenesis and Obesity

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 2, 2012, Pages 283-295

  Garten, A ^a   Schuster, S ^a   Kiess, W ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Adipogenesis; Growth hormone; Insulin like growth factors; Obesity

Indexed keywords

GROWTH HORMONE RECEPTOR; INSULIN; INSULIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VOLUME; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UPREGULATION;

ADIPOGENESIS; ANIMALS; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MICE; OBESITY; RATS; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 84861970804     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.04.011     Document Type: Review

References (76)

1. Wabitsch M., Hauner H., Heinze E., et al. The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism 1995, 44(10 Suppl 4):45-49.
2. Blüher S., Kratzsch J., Kiess W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab 2005, 19:577-587.
3. Gahete M.D., Durán-Prado M., Luque R.M., et al. Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology. Ann N Y Acad Sci 2009, 1163:137-153.
4. Møller N., Jørgensen J.O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009, 30:152-177.
5. Kaplan S.A., Cohen P. The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 2007, 92:4529-4535.
6. Wabitsch M., Braun S., Hauner H., et al. Mitogenic and antiadipogenic properties of human growth hormone in differentiating human adipocyte precursor cells in primary culture. Pediatr Res 1996, 40:450-456.
7. Wabitsch M., Heinze E., Hauner H., et al. Biological effects of human growth hormone in rat adipocyte precursor cells and newly differentiated adipocytes in primary culture. Metabolism 1996, 45:34-42.
8. Zhao J.T., Cowley M.J., Lee P., et al. Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: a gene expression study in hypopituitary men. J Clin Endocrinol Metab 2011, 96:E1188-E1196.
9. Vijayakumar A., Novosyadlyy R., Wu Y., et al. Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res 2010, 20:1-7.
10. Möller C., Arner P., Sonnenfeld T., et al. Quantitative comparison of insulin-like growth factor mRNA levels in human and rat tissues analysed by a solution hybridization assay. J Mol Endocrinol 1991, 7:213-222.
11. Klöting N., Koch L., Wunderlich T., et al. Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 2008, 57:2074-2082.
12. Bäck K., Brännmark C., Strålfors P., et al. Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes-role of insulin and IGF-I receptors. Mol Cell Endocrinol 2011, 339:130-135.
13. Sato T., Nagafuku M., Shimizu K., et al. Physiological levels of insulin and IGF-1 synergistically enhance the differentiation of mesenteric adipocytes. Cell Biol Int 2008, 32:1397-1404.
14. Nezer L., Moreau B., Brouwers W., et al. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet 1999, 21:155-156.
15. Bellows C.G., Jia D., Jia Y., et al. Different effects of insulin and insulin-like growth factors I and II on osteoprogenitors and adipocyte progenitors in fetal rat bone cell populations. Calcif Tissue Int 2006, 79:57-65.
16. Boney C.M., Moats-Staats B.M., Stiles A.D., et al. Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 1994, 135:1863-1868.
17. Wabitsch M., Heinze E., Debatin K.M., et al. IGF-I and IGFBP-3-expression in cultured human preadipocytes and adipocytes. Horm Metab Res 2000, 32:555-559.
18. Chan S., Twigg S., Firth S., et al. Insulin-like growth factor binding protein 3 leads to insulin resistance in adipocytes. J Clin Endocrinol Metab 2005, 90:6588-6595.
19. Baxter R.B., Twigg S.M. Actions of IGF binding proteins and related proteins in adipose tissue. Trends Endocrinol Metab 2009, 20:499-505.
20. Siddals K.W., Westwood M., Gibson J.M., et al. IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte. J Endocrinol 2002, 174:289-297.
21. Rajkumar K., Modric T., Murphy L.J. Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice. J Endocrinol 1999, 162:457-465.
22. Wheatcroft S.B., Kearney M.T., Shah A.M., et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 2007, 56:285-294.
23. Iida K., Takahashi Y., Kaji H., et al. Diverse regulation of full-length and truncated growth hormone receptor expression in 3T3-L1 adipocytes. Mol Cell Endocrinol 2003, 210:21-29.
24. Bäck K., Arnqvist H.J. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Horm IGF Res 2009, 19:101-111.
25. Gardan D., Mourot J., Louveau I. Decreased expression of the IGF-II gene during porcine adipose cell differentiation. Mol Cell Endocrinol 2008, 292:63-68.
26. Rosenfeld R.G., Hwa V. New molecular mechanisms of GH resistance. Eur J Endocrinol 2004, 151:S11-S15.
27. Clarkson R.W., Chen C.M., Harrison S., et al. Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta. Mol Endocrinol 1995, 9:108-120.
28. Kilgour E., Gout I., Anderson N.G. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways. Biochem J 1996, 315:517-522.
29. VanderKuur J.A., Butch E.R., Waters S.B., et al. Signalling molecules involved in coupling growth hormone receptor to MAP kinase activation. Endocrinology 1997, 138:4301-4307.
30. Vesterlund M., Zadjali F., Persson T., et al. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS One 2011, 6:e25358.
31. Picard F., Kurtev M., Chung N., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429:771-776.
32. Fischer-Posovszky P., Kukulus V., Tews D., et al. Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am J Clin Nutr 2010, 92:5-15.
33. Qin Y., Tian Y.P. Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice. J Transl Med 2010, 8:120.
34. Cuesta S., Kireev R., Forman K., et al. Growth hormone can improve insulin resistance and differentiation in pancreas of senescence accelerated prone male mice (SAMP8). Growth Horm IGF Res 2011, 21:63-68.
35. Kralisch S., Klein J., Lossner U., et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005, 185(3):R1-R8.
36. Soliman G.A., Acosta-Jaquez H.A., Fingar D.C. mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes. Lipids 2010, 45:1089-1100.
37. Hayashi A.A., Proud C.G. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. Am J Physiol Endocrinol Metab 2007, 292:E1647-E1655.
38. Thirone A.C., Carvalho C.R., Saad M.J. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Endocrinology 1999, 140:55-62.
39. Huang Y., Kim S.O., Yang N., et al. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements. Mol Endocrinol 2004, 18:1471-1485.
40. Laplante M., Sabatini D.M. An emerging role of mTOR in lipid biosynthesis. Curr Biol 2009, 19:R1046-R1052.
41. Sekimoto H., Boney C.M. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation. Endocrinology 2003, 144:2546-2552.
42. Jiang Z.Y., Zhou Q.L., Holik J., et al. Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells. J Biol Chem 2005, 280(22):21622-21628.
43. Sasaki-Suzuki N., Arai K., Ogata T., et al. Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2009, 284:6061-6070.
44. Fukuoka H., Iida K., Nishizawa H., et al. IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes. Growth Horm IGF Res 2010, 20:212-219.
45. Chan S.S., Schedlich L.J., Twigg S.M., et al. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. Am J Physiol Endocrinol Metab 2009, 296:E654-E663.
46. Ricort J.M., Binoux M. Insulin-like growth factor binding protein-3 stimulates phosphatidylinositol 3-kinase in MCF-7 breast carcinoma cells. Biochem Biophys Res Commun 2004, 314:1044-1049.
47. Morikawa M., Nixon T., Green H. Growth hormone and the adipose conversion of 3T3 cells. Cell 1982, 29:783-789.
48. Fischer-Posovszky P., Tornqvist H., Debatin K.M., et al. Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit. Endocrinology 2004, 145:1849-1859.
49. Scavo L.M., Karas M., Murray M., et al. Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes. J Clin Endocrinol Metab 2004, 89:3543-3553.
50. Hauner H., Entenmann G., Wabitsch M., et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989, 84:1663-1670.
51. Maison P., Griffin S., Nicoue-Beglah M., et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 2004, 89:2192-2199.
52. Ukropec J., Penesová A., Skopková M., et al. Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements. J Clin Endocrinol Metab 2008, 93:2255-2262.
53. Erman A., Veilleux A., Tchernof A., et al. Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women. Int J Obes (Lond) 2011, 35:1511-1519.
54. Kreitschmann-Andermahr I., Suarez P., Jennings R., et al. GH/IGF-I regulation in obesity-mechanisms and practical consequences in children and adults. Horm Res Paediatr 2010, 73:153-160.
55. Thomas G.A., Kraemer W.J., Kennett M.J., et al. Immunoreactive and bioactive growth hormone responses to resistance exercise in men who are lean or obese. J Appl Physiol 2011, 111:465-472.
56. Kratzsch J., Dehmel B., Pulzer F., et al. Increased serum GHBP levels in obese pubertal children and adolescents: relationship to body composition, leptin and indicators of metabolic disturbances. Int J Obes Relat Metab Disord 1997, 21:1130-1136.
57. Cornford A.S., Barkan A.L., Horowitz J.F. Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. J Clin Endocrinol Metab 2011, 96:824-830.
58. Nam S.Y., Lee E.J., Kim K.R., et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997, 21:355-359.
59. Laron Z., Avitzur Y., Klinger B. Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism 1995, 44(Suppl 4):113-118.
60. Laron Z., Ginsberg S., Lilos P., et al. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin Endocrinol (Oxf) 2006, 65:114-117.
61. Mauras N., Martinez V., Rini A., et al. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism. J Clin Endocrinol Metab 2000, 85:3036-3042.
62. Tchkonia T., Tchoukalova Y.D., Giorgadze N., et al. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab 2005, 288:E267-E277.
63. McLaughlin T., Lamendola C., Liu A., et al. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011, 96:E1756-E1760.
64. DiGirolamo M., Fine J.B., Tagra K., et al. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. Am J Physiol 1998, 274:R1460-R1467.
65. Villafuerte B.C., Fine J.B., Bai Y., et al. Expressions of leptin and insulin-like growth factor-I are highly correlated and region-specific in adipose tissue of growing rats. Obes Res 2000, 8:646-655.
66. Cleveland-Donovan K., Maile L.A., Tsiaras W.G., et al. IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology 2010, 151:3752-3763.
67. Bashan N., Dorfman K., Tarnovscki T., et al. Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 2007, 148:2955-2962.
68. Freda P.U., Shen W., Heymsfield S.B., et al. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab 2008, 9:2334-2343.
69. Shepherd P.R., Gnudi L., Tozzo E., et al. Adipose tissue hyperplasia and enhanced glucose disposal in transgenic mice over-expressing GLUT 4 selectively in adipose tissue. J Biol Chem 1993, 268:22243-22246.
70. Ozanne S.E., Jensen C.B., Tingey J.K., et al. Decreased protein levels of key insulin signaling molecules in adipose tissue from young men with a low birthweight-potential link to increased risk of diabetes?. Diabetologia 2006, 49:2993-2999.
71. Iñiguez G., Ormazabal P., López T., et al. IGF-1R/ERK content and response to IGF-I and insulin in adipocytes from small for gestational age children. Growth Horm IGF Res 2009, 19:256-261.
72. Yakar S., Setser J., Zhao H., et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 2004, 113:96-105.
73. Gravholt C.H., Schmitz O., Simonsen L., et al. Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. Am J Physiol 1999, 277:E848-E854.
74. Wurzburger M.I., Prelevic G.M., Sonksen P.H., et al. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes. J Clin Endocrinol Metab 1993, 77:267-272.
75. Varela-Nieto I., Hartl M., Gorospe I., et al. Anti-apoptotic actions of insulin-like growth factors: lessons from development and implications in neoplastic cell transformation. Curr Pharm Des 2007, 13:687-703.
76. Paharkova-Vatchkova V., Lee K.W. Nuclear export and mitochondrial and endoplasmic reticulum localization of IGF-binding protein 3 regulate its apoptotic properties. Endocr Relat Cancer 2010, 17:293-302.